Correlation Between SAB Biotherapeutics and Altamira Therapeutics

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Altamira Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Altamira Therapeutics.

Diversification Opportunities for SAB Biotherapeutics and Altamira Therapeutics

0.0

Correlation Coefficient

SAB Biotherapeutics  Altamira Therapeutics

Pay attention - limited upside

The 3 months correlation between SAB and Altamira is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Altamira Therapeutics go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Altamira Therapeutics

If you would invest  6.75  in SAB Biotherapeutics on November 28, 2024 and sell it today you would lose (3.75) from holding SAB Biotherapeutics or give up 55.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

SAB Biotherapeutics  vs.  Altamira Therapeutics

SAB Biotherapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Altamira Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Altamira Therapeutics is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with SAB Biotherapeutics and Altamira Therapeutics

The main advantage of trading using opposite SAB Biotherapeutics and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.

The idea behind SAB Biotherapeutics and Altamira Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.